Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India’s life sciences sector: A vision for budget FY2025
Focus on enabling MSME business, expanding PLI scheme and research-linked incentives to foster API innovation and tax incentives…
CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab
Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…
Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada
DFE Pharma appoints Sven Abend as new CEO
Abend brings 25 years of global business leadership experience, with a track record of driving customer-centric strategies and…
Pharma Leadership and Innovation Conclave 2025 | 21st February 2025
21st February 2025 | Hilton, Mumbai International Airport
Pharmapack outlines pharma trends 2025, highlights market optimism despite uncertainty
Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025,…
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3…
Brexpiprazole is an atypical antipsychotic used as an adjunctive therapy to antidepressants for the treatment of major depressive…
Indian Immunologicals hosts pandemic preparedness conclave in Hyderabad
The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust…
Vitafoods India 2025 – Redefining and connecting the nutraceutical ecosystem to drive growth and…
Over 8,000 visitors expected at Vitafoods India 2025, highlighting the event's growing role as a key networking hub
FDA accepts Eisai’s BLA for LEQEMBI subcutaneous autoinjector for alzheimer’s disease treatment
LEQEMBI’s subcutaneous formulation could simplify maintenance therapy for Alzheimer’s patients, offering a 15-second at-home…